key: cord-0683237-ccv3ck0n
authors: Robinson, Bruce M.; Guedes, Murilo; Alghonaim, Mohammed; Cases, Aleix; Dasgupta, Indranil; Gan, Liangying; Jacobson, Stefan H.; Kanjanabuch, Talerngsak; Kim, Yong-Lim; Kleophas, Werner; Labriola, Laura; Perlman, Rachel L.; Reboldi, Gianpaolo; Srivatana, Vesh; Suri, Rita S.; Tsuruya, Kazuhiko; Torres, Pablo Urena; Pisoni, Ronald L.; Pecoits-Filho, Roberto
title: Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion
date: 2021-05-14
journal: Kidney Med
DOI: 10.1016/j.xkme.2021.03.006
sha: dc2acf720c2dd33a32c59ebe4329af4ec95363f5
doc_id: 683237
cord_uid: ccv3ck0n

As the worst global pandemic of the past century, COVID-19 has had a disproportionate effect on maintenance dialysis patients and their health care providers. At a virtual roundtable on 12 June 2020, DOPPS investigators from fifteen countries in Asia, Europe, and the Americas described and compared the effects of COVID-19 on dialysis care, with recent updates added. Most striking is the huge difference in risk to dialysis patients and staff across the world. Per-population cases and deaths among dialysis patients vary over 100-fold across participating countries, mirroring burden in the general population. International data indicate case fatality ratio remains at 10-30% among dialysis patients, confirming the gravity of infection, and that cases are much more common among in-center than home dialysis patients. This latter finding merits urgent study because in-center patients often have greater community exposure, and in-center transmission may be uncommon under optimal protocols. Greater telemedicine use is a welcome change here to stay, and our community needs to improve emergency planning and protect dialysis staff from the next pandemic. Finally, the pandemic’s challenges have prompted widespread partnering and innovation in kidney care and research that must be sustained after this global health crisis.

First identified in Wuhan, China, in late 2019, the novel coronavirus SARS-CoV-2 is the cause of the worst global pandemic in our lifetimes. To better understand the impact of COVID-19 on dialysis patients globally, we hosted a virtual roundtable on 12

June 2020 with DOPPS investigators around the world to capture their early pandemic experiences, both objective and personal. This report summarizes presentations from fifteen countries in Asia, Europe, and the Americas, along with updates based on more recent impressions and the most current epidemiologic data.

The impact of COVID-19 has varied dramatically, with cases and deaths in the general population varying over 100-fold across participating countries ( Figure 1 ). 1 Our panelists summarized national data for dialysis populations, based on registry reports, claims-based reports, or society surveys ( Figure 2 , Table 1 ), and contextualized these findings. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Predictably but sobering, per-population cases and deaths among dialysis patients vary by 10-to 100-fold, as in the general population ( Figure 3 ). Common across countries, published center and regional experiences report lower infection risk among home dialysis patients, but also confirm that outcomes among infected persons are poor for both home and in-center dialysis patients, with case fatality ratios of at least one in ten for persons diagnosed by targeted testing.

Now one year into this pandemic and with vaccination providing the real hope for eventual containment, the picture emerging from the early pandemic period is of dialysis staff working courageouslyeven heroicallyto keep patients safe and cared for, and of dialysis patients doing their utmost to reduce their infection risk. Lessons learned from these extraordinary circumstances have been adopted quickly, with our community J o u r n a l P r e -p r o o f 4 functioning in many ways as a higher-level learning health system, 14 sharing information, partnering, and issuing interim guidance at speeds and across divides as never before. [15] [16] [17] [18] Despite these commendable achievements, the pandemic provides stark illustration that the dialysis community is inexorably linked to society, beholden to circumstances outside our control. In parts of the world, dialysis patients and staff have remained generally shielded by effectively-adopted public health prevention and containment measures, while in others the most scrupulous attention at the dialysis clinic cannot overcome the impact of uncontained community spread on patients with kidney failure, among those at very highest risk from the scourge of COVID-19.

On a per population basis, the number of COVID-19 cases and deaths is strikingly lower in many Asian countries than elsewhere. Especially impressive, we see this trend across diverse cultures, geographies, and country income groups across the continent.

Box 1 provides panelists' impressions of some reasons for success in countries that have limited the spread of COVID-19 in the general population. 6 Among patients undergoing dialysis, there were 522 documented cases of SARS-CoV-2 as of Dec 2020, despite having the world's second largest dialysis population. 12 Academic and professional societies involved in dialysis therapy quickly proposed strategies and recommendations for the prevention and management of COVID-19 infection. 25 This guidance is generally aligned with best practices elsewhere and has been strictly followed.

In Korea, new cases peaked at the end of February 2020 and again in the middle of December 2020. From the start, screening, case isolation, and contact tracing were adopted rapidly and widely (Box 1). All in all, success has been achieved despite no border shut-down or travel restriction. The impact on society and the economy has been profound but less than feared. Daegu, with a 2.5 million metropolitan population, was the original COVID-19 epicenter in Korea, with 0.3% prevalence and 2.5% case fatality ratio in the general population. The first patient with COVID-19 receiving in-center HD, on 19

February 2020, resulted in 302 people placed on contact isolation. 26 From the earliest days, most HD centers educated patients to self-assess for symptoms before arriving for dialysis. Symptomatic patients were tested immediately by RT-PCR. Confirmed cases were transferred to an HD center with a negative pressure room. Close contacts with negative tests were isolated for 2 weeks and dialyzed in cohorted sessions. To date, case load has been low in Daegu and across Korea, and no PD patients have been infected (Table 1) .

J o u r n a l P r e -p r o o f 7   Thailand was one of the first countries outside China with a confirmed SARS-CoV-2 case, in mid-January 2020. Containment policies (Box 1) were implemented rapidly and successfully. Compliance was high, as traffic density was 15-20% less than usual, with 95% facemask and 89% hand sanitizer use. 27, 28 To date, there has been only one documented case (who died) among a Thai dialysis population of approximately 100,000. 29 Recommendations from health authorities and kidney organizations were disseminated in April 2020. Among these, health care providers are expected to use telemedicine to monitor patients' health and keep patients informed about the latest safety guidance. The lesson to-date from Thailand is that voluntary compliance by nearly all citizens, and voluntary service of grassroots public health activists cooperating with a large cadre of health authorities, can effectively contain this pandemic, at the same time protecting our patients with kidney failure. Efforts are now focused on combatting the country's second wave, which began in late December 2020.

Saudi Arabia confirmed its first SARS-CoV-2 case on 2 March 2020, later than many countries. The number of known cases and fatalities rose sharply through summer 2020, attributed to increased screening toward a 40% population target. Cases 

Many European countries, along with their dialysis patients and staff, suffered the brunt of the early pandemic in the first months of 2020 ( Figure 1 ). 30 In most western European countries, containment of COVID-19 improved before a second large wave hit late in 2020.

The first Belgian case of COVID-19 was diagnosed on 4 February 2020, with lockdown on 18 March, peak on 7 April 2020, and then exponential decline. On the 

France was hard hit early on by COVID-19. 8 

The first larger Covid-19 outbreak in Germany hit on 26 February 2020. As the virus spread, hot spots were linked to working conditions, especially meat factories. From the beginning, cases were identified among dialysis patients and staff. Responses were issued rapidly by authorities and the German Society of Nephrology (DGfN). 9, 31 Providers, associations, and experts met frequently to establish best practices for diagnosis, triage, isolation, transportation, hygiene, PPE use, and more, and a national registry was implemented. Meticulous federal and local interventions (Box 1), implemented early and followed seriously by the general public, have helped limit the pandemic's spread. 32 As such, COVID-19 per-population cases and deaths were among the lowest in Europe during the first wave, and remain so despite a protracted second wave since October 2020.

Italy was hit overwhelmingly early in the COVID-19 pandemic, and its population with kidney failure was not spared. 33, 34 The Italian Society of Nephrology J o u r n a l P r e -p r o o f 10 (SIN) published survey results from all 454 renal care centers as of June 2020. 6 Infection risk differed substantially by geographical latitude, and home treatment was linked to lower risk of SARS-CoV-2 infection. The SIN's recommended preventive measures were adopted by all centers. The majority of centers tested only symptomatic patients and staff, while 16% and 30% adopted "test-all" policies for patients and staff, respectively. All centers restricted dialysis unit access, 62% conducted telephone triage between sessions, and 88% changed to individual transport for confirmed or suspected cases. The SIN's second COVID-19 survey is underway as of late 2020.

The 

The Stockholm region has been most affected by COVID-19. When the pandemic first struck, there was rapid, coordinated reorganization among the hospital systems, with the large acute university hospitals focusing on COVID-19 and doubling ICU capacity within days. New teams and collaborations were established swiftly, with close to 100% of ICU beds occupied by COVID-19 patients and most on ventilators. 39 The Swedish

Renal Registry is collecting COVID-19 data from all dialysis centers, not yet available.

During the first wave, only 10-15% of HD patients at our center with RT-PCR-positive SARS-CoV-2 required hospitalization. The majority had no or mild symptoms and continued to receive outpatient dialysis, even among older and frail persons. Our dialysis practice isolated COVID-19 cases to specific dialysis facilities. To increase capacity, patients receiving four or five dialysis sessions per week were reduced to thrice weekly, but not less. The outpatient clinic switched almost entirely to telemedicine visits, which has worked well and will continue after the pandemic.

The United Kingdom has amongst the world's highest mortality from COVID-19, with serious first, second, and now (since December 2020) third waves. UK Renal Registry data show that patients with kidney failure have been disproportionately affected

Brazil is among the countries worst hit by COVID-19 worldwide. In Brazil, 80% of dialysis centers are covered by a public health care system, already financially strapped and now severely strained by the pandemic. The Brazilian Society of Nephrology issued COVID-19 management recommendations in May 2020. 45 In a nationwide survey through June 2020, 12% of dialysis staff had confirmed or suspected COVID-19, with two reported deaths 11 . Cases and case fatality ratios among dialysis patients were much higher than in the general population, and higher still in regions such as the northeast and north with lower economic resources.

Chronic dialysis units are responsible for dialysis support for many patients with AKI, mainly through intermittent HD. Because approximately 30% of severely affected COVID-19 patients require dialysis, staff and resources have been markedly strained.

Virtual clinic visits are now much more common for PD patients. Kidney transplants, typically 5000 per year, are projected to decrease by at least 50% in 2020.

Canada's first case of COVID-19 was identified in late January 2020. By March, coordinated public health strategies were issued and followed widely (Box 1). By mid-June 2020, the country had successfully flattened the curve 46 . Quebec was hardest hit by far, with roughly 3-fold higher cases and deaths per population than Ontario, the most Rachel Perlman, Ann Arbor, Michigan: Ann Arbor is one hour from Detroit, an early COVID-19 "hotspot" highlighting health care inequities by race. African Americans comprise 14% of the state's population, but 40% of COVID-19 deaths. 49 The governor of Michigan issued a 'stay-at-home' order on 15 March 2020, soon after the state's first cases were diagnosed. The number of new cases declined markedly after May 2020, though has now risen dramatically since October 2020 along with the sustained second wave nationwide.

When the pandemic began, uncertainty led to fear that dialysis patients could be exposed to COVID-19 through the health system, that it might spread rapidly through the HD unit, and that it could be brought home to families. We are less fearful now, but weary that COVID-19 is not going away soon. Until mid-summer, we did not have capacity to test all symptomatic dialysis patients, let alone screen asymptomatic patients.

Among our three outpatient units, one evening shift was designated the "COVID shift."

Happily, staff were very willing to volunteer for this shift. Even our patients who do not always "follow the rules" have reported strict social distancing, and we have had good treatment adherence, perhaps because COVID-19 has scared patients. Our large home dialysis program shifted to telemedicine visits whenever possible, and was greatly appreciated by patients.

The first SARS-CoV-2 vaccines were approved in December 2020 in 10 of our panel's 15 countries: China (Sinopharm); the UK (Pfizer/BioNTech, Oxford/AstraZeneca); Saudi Arabia (Pfizer/BioNTech); and Canada, the US, and the six other European countries (Moderna, Pfizer/BioNTech). Approval in Brazil followed in January 2021 (Oxford/AstraZeneca, Sinopharm). 1 Thailand, Japan and Korea all began vaccinating in February 2021. While dialysis staff are highest, or nearly highest, priority in all countries, extensive vaccination of patients will be a challenge for months to come.

A diagnosis of kidney failure qualifies for first priority vaccination, among non-health care workers, in a few countries but is somewhat lower tier in most. In the US, states and local communities have discretion regarding prioritization and allocation of limited vaccine supply. Dialysis providers are advocating for direct allocation to dialysis centers, but this is uncommon to date. 50 Until this changes, some of our most vulnerable dialysis patients will be unvaccinated for months to come.

Infection with SARS-CoV-2 is grave for many dialysis patients, with case fatality ratios in the 10-30% range to date among cases diagnosed by selected testing. The most recent data have not shown any improvement in case fatality ratios to date, despite favorable trends in case fatality ratios in national data (attributed to increased testing among other reasons). In the pandemic's early months, intense efforts centered on optimal testing, control, and cohorting strategies to protect dialysis patients and staff.

Impressions from our panelists suggest that dialysis centers around the globe have byand-large embraced recommended practices, with the caveat that access to diagnostic testing was suboptimal in hard-hit regions, and still is in some locales. [15] [16] [17] [18] Despite this, as we enter the second year of the pandemic, dialysis clinics continue to face vastly different realitieswith the number of COVID-19 deaths logarithmically higher in some geographies than othersdue overwhelmingly to community burden ( Figure 3 ). As such, societal-level forces continue to put dialysis patients in some regions at undue risk from COVID-19. Notably, Figure 3 illustrates that the UK has the highest proportion of cases, and correspondingly deaths, among dialysis patients. Further evaluation is needed to understand whether this observation reflects reporting differences or true elevated risk.

This report is limited to high and upper-middle income countries, and does not address the reality that lower income countries may be less well positioned to limit the spread of COVID-19 in kidney care units and to support infected patients. DOPPS and the International Society of Nephrology are collecting COVID-19-related survey data from dialysis centers worldwide, with initial findings expected shortly. 51 The intense challenges of the pandemic have prompted innovation across dialysis care in sufficiently resourced countries, proving that 'necessity is the mother of invention.' Our panelists' perspectives on some effects on dialysis care beyond COVID-19 are summarized in Table 2 . Questions that will play out over the coming months and years include:

 Will the advantages of telemedicine and home dialysis lead to greater use after the pandemic? Telemedicine is undoubtedly a big win, but any shift to greater utilization of home dialysis is unclear. SARS-CoV-2 cases have been much higher among incenter HD than home dialysis patients. However, in-center HD patients are more likely to have community exposure, e.g., as long-term care residents, and anecdotal data indicate that transmission is rare within in-center HD units following infection control protocols. As data accrue, this possibility merits urgent study and will surely underpin the extent to which COVID-19 drives longer-term uptake of home dialysis.

 Will heightened 'universal precautions' become the new standard-of-care after the pandemic to limit nosocomial infections? While the likely decline in nosocomial infections would benefit all, sustaining this change will struggle against up-front costs and the temptation of complacency.

 What is the new standard for emergency planning for the next pandemic? Where resources allow, 52 this should undoubtedly include review of emergency supply chain capacities, plans to rapidly deploy dialysis 'isolation' shifts or centers, and resourcing to cover surges in acute dialysis needs without compromising long-term dialysis care.

New urgent-PD and PD-first programs may be established by some sites.

 How can we better protect staff from unacceptably high physical risks and stress that some have been exposed to? As a start, we need to understand the extent of the psychological impact of this pandemic on dialysis staff, and to assure availability of post-trauma support services. Moving forward, staffing protection and contingency plans need to be in place, and staff must have a real 'voice at the table.'

Finally, can the kidney community join forces to more quickly bring innovation to market, develop the highest quality evidence, publish consensus guidelines, and share resources to meaningfully improve the lives of patients with kidney failure? Time will tell as, with society at large, we eventually emerge from this global health crisis. For each country, most recent data from Jan 2020 to Aug 2020 is provided in first row; if available, most recent data from Sep 2020 to Jan 2021 is provided in second row

Data not available for cells with '-.' Countries not shown: Sweden (national data collection underway by the Swedish Renal Registry); China (national data not available; see text for regional publications)

Germany  The federally organized German health care system mandates reporting for proven or serious suspected SARS-CoV-2 cases  Local authorities have run contact tracing programs since very early in the pandemic  The Robert Koch Institute (Germany's public health institute) 25 issues case reporting contact risk stratification at the local level, enabling health care operations to adjust accordingly while maintaining efficient operations

Canada  The government quickly closed the border to all foreign nationals, and all provinces declared States of Emergency, closing schools and non-essential businesses, and enforcing physical distancing measures  Public and private in-home gatherings were prohibited  Mask-wearing, although initially not mandatory, was practiced by government officials and the majority of the population in public spaces  Messaging from all levels of government was repeated, authoritative, and generally consistent Asia Japan  Strict preventive practices were implemented quickly, including the expectation for all to wash hands, wear masks, socially distance, and stay home as much as possible  These practices generally align with deeply rooted Japanese cultural practices, such as very little "skinship" (hugging or shaking hands) and not wearing shoes in the house, and have been closely followed Korea J o u r n a l P r e -p r o o f 32  RT-PCR use has been widespread since early in the pandemic (one million tests as of 11 June), and drive-thru screening centers were quickly set up  Contact tracing has been scrupulous from the start  Asymptomatic or mild cases of COVID-19 were isolated in therapeutic living centers; this limited spread and avoided acute shortages of hospital beds Thailand  The Thai government deployed a "soft" lockdown, securing the country border, stopping international and interprovincial transports, executing a night curfew, and shutting non-essential establishments  Public campaigns promoting hygienic practices were implemented to wear face masks, observe social distancing, and stay at home, bolstered by millions of grassroots volunteers and media support  Coercive measures included contact tracing, quarantining suspected cases, and confining international travelers in state quarantine centers Which changes will persist over the next year or beyond, compared to before COVID-19? 1: Jan 2020 to Aug 2020 2: Sept 2020 to Jan 2021

Published online at OurWorldInData.org. (2020) Retrieved from

Epidémiologie du COVID-19 en Belgique Francophone. Société Française de Néphrologie

The Renal Association. COVID-19 surveillance report for renal centres in the UK

Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology

COVID-19 and kidney transplantation: an Italian Survey and Consensus

Situation de l'épidémie de Covid-19 chez les patients dialysés et greffés rénaux en France

Nierenersatztherapie in Zeiten von SARS-CoV-2 in Deutschland. Nieren-und Hochdruckkrankheiten

Preliminary Medicare COVID-19 Data Snapshot

High mortality of CKD patients on hemodialysis with Covid-19 in Brazil

Japanese Association of Dialysis Physicians

The Korean Society of Nephrology COVID-19 Task Force Team (www.ksn.or.kr) and Korean CDC

Toward a science of learning systems: a research agenda for the high-functioning Learning Health System

Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres

Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant

Mitigating risk of COVID-19 in dialysis facilities

COVID-19 in dialysis patients: outlasting and outsmarting a pandemic. Kidney International

Clinical characteristics of coronavirus disease 2019 in China

Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan

COVID-19 in Peritoneal Dialysis Patients

COVID-19 Expert Team of Chinese Society of Nephrology. Recommendations for prevention and control of novel coronavirus infection in blood purification center (room) from the Chinese Medical Association Nephrology Branch

The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients

Japanese Society of Nephrology, et al. COVID-19 of dialysis patients in Japan: Current status and guidance on preventive measures

Hemodialysis with cohort isolation to prevent secondary transmission during a COVID-19 outbreak in Korea

How Thailand Contained COVID-19

UK: Imperial College London

Global dialysis perspective: Thailand. Kidney360

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney international

A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection

Società Italiana di Nefrologia (2020) Coronavirus disease

COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain

High prevalence of asymptomatic COVID-19 in haemodialysis: learning day by day in the first month of the COVID-19 pandemic

Aprendiendo día a día el primer mes de pandemia de COVID-19

Impact of the COVID-19 pandemic on

The need for an independent evaluation of the COVID-19 response in Spain

42. NICE Guideline. COVID-19 rapid guideline: dialysis service delivery

The Renal Association. RA resources for renal professionals

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

The Brazilian Society of Nephrology and the Covid-19 Pandemic

COVID-19 Emergency Preparedness For Healthcare Professionals

CSN COVID-19 Rapid Response Team (CCRRT) Recommendations To Be Published In The Canadian Journal Of Kidney Health And Disease

Michigan Department of Health and Human Services

Dialysis Providers Push for Direct Allocation of COVID-19 Vaccines

ISN Teams Up With DOPPS To Survey The Impact Of Covid-19 On Dialysis Patients. International Society of Nephrology

End Stage Renal Disease Community Covid-19 After-Action Report And Improvement Plan. Kidney Community Emergency Response

USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

KSN 2020, Virtual Meeting

COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider

Peritoneal Dialysis during the coronavirus Disease-2019 (COVID-19) pandemic: acute inpatient and maintenance outpatient experiences

Home dialysis use will continue to grow. *Panelists were asked to state impact on practice during the pandemic's peak to-date, as of August 2020. 1 Answer options: markedly decreased/worsened (↓↓), somewhat decreased/worsened (↓), unchanged (-), somewhat increased/improved (↑), markedly increased/improved (↑↑); Panelists were asked to state the impact on practice during the pandemic's peak to-date, as of August 2020. 2